Hoppu K, Koskimies O, Tuomisto J
Clin Pharmacol Ther. 1987 Aug;42(2):181-6. doi: 10.1038/clpt.1987.130.
We studied the pharmacokinetics of trimethoprim in 14 children (two neonates) with renal insufficiency. They were 1 week to 16.4 years old and had glomerular filtration rates (GFR) between 10.8 to 72.3 ml/min/1.73 m2. The half-life (t1/2) of trimethoprim was inversely related to the GFR. The relation followed a power curve (correlation of t1/2 with GFR: r = -0.86; P less than 0.001). The slower elimination rate was mainly the result of lowered renal clearance of trimethoprim. The volume of distribution (Varea) was, in most patients, in the upper normal range for children. In some of the patients, chiefly infants with severe renal insufficiency, the Varea was larger than normal. In some individuals the pharmacokinetics of trimethoprim deviated from that to be expected from the GRF. We recommend reduced daily doses of trimethoprim if the GFR is less than 30 ml/min/1.73 m2. The reduction should be proportional to the reduction in GFR and primarily take the form of a prolonged dose interval.
我们研究了14名肾功能不全儿童(两名新生儿)中甲氧苄啶的药代动力学。他们年龄在1周至16.4岁之间,肾小球滤过率(GFR)在10.8至72.3 ml/min/1.73 m²之间。甲氧苄啶的半衰期(t1/2)与GFR呈负相关。这种关系呈幂曲线(t1/2与GFR的相关性:r = -0.86;P小于0.001)。消除速率减慢主要是甲氧苄啶肾清除率降低的结果。在大多数患者中,分布容积(Varea)处于儿童正常范围的上限。在一些患者中,主要是患有严重肾功能不全的婴儿,Varea大于正常。在一些个体中,甲氧苄啶的药代动力学偏离了根据GRF预期的情况。我们建议,如果GFR小于30 ml/min/1.73 m²,应减少甲氧苄啶的每日剂量。减少应与GFR的降低成比例,主要采取延长给药间隔的形式。